Your shopping cart is currently empty

Mps1-IN-1 is a potent, selective, and ATP-competitive inhibitor of Mps1 kinase (IC50: 367 nM).

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $39 | In Stock | In Stock | |
| 5 mg | $90 | In Stock | In Stock | |
| 10 mg | $169 | In Stock | In Stock | |
| 25 mg | $333 | In Stock | In Stock | |
| 50 mg | $498 | In Stock | In Stock | |
| 100 mg | $723 | In Stock | In Stock | |
| 1 mL x 10 mM (in DMSO) | $107 | In Stock | In Stock |
| Description | Mps1-IN-1 is a potent, selective, and ATP-competitive inhibitor of Mps1 kinase (IC50: 367 nM). |
| Targets&IC50 | CLK1:1900 nM (kd), PYK2:280 nM (kd), TNK1:2600 nM (kd), ERK2:2900 nM (kd), Insulin receptor:470 nM (kd), Mps1:27 nM (kd), GAK:1100 nM (kd), TNK2:3100 nM (kd), Insulin receptor related receptor:1200 nM (kd), IGF-1R:750 nM (kd), FAK:440 nM (kd), Mps1:367 nM, ALK:21 nM (kd), TYK1/LTK:29 nM (kd) |
| In vitro | Mps1-IN-1 is a potent, selective, and ATP-competitive inhibitor of Mps1 kinase with IC50 and Kd values of 367 nM and 27 nM, respectively. It also exhibits high affinity for ALK and LTK, with Kd values of 21 nM and 39 nM, respectively[1]. |
| Molecular Weight | 535.66 |
| Formula | C28H33N5O4S |
| Cas No. | 1125593-20-5 |
| Smiles | COc1cc(ccc1Nc1cc(Nc2ccccc2S(=O)(=O)C(C)C)c2cc[nH]c2n1)N1CCC(O)CC1 |
| Relative Density. | 1.354 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 39 mg/mL (72.81 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (3.73 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | ||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||
DMSO
| |||||||||||||||||||||||||||||||
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.